Local steroid therapy in cutaneous hemangiomas
Gangopadhyay, A.N.; Sharma, S.P.; Gopal, S.C.; Gupta, D.K.; Panjawani, K.; Sinha, J.K.
Indian Pediatrics 33(1): 31-33
1996
ISSN/ISBN: 0019-6061 PMID: 8772948 Document Number: 467581
To evaluate the efficacy of intralesional triamcinolone in enhancing regression in various type of hemangiomas. Outpatients department of a teaching hospital Subjects: One hundred and five patients with rapidly growing surface hemangioma. The age ranged from 1 month to 15 months (mean 7 months). Intralesional triamcinolone administered at monthly intervals, ranging from single injection to 7 injections (mean 3.6 injections). Regression of the hemangioma. The overall response rate was 88.6% (excellent 51.4%, and good 37.2%). Maximum response was observed in children below 1 year of age (> 90%), lesions over the face (92.8%) and strawberry hemangiomas (99.9%). Intralesional administration of triamcinolone devoid of systemic side effects and an effective initial modality for rapidly growing hermangiomas.